29 July 2009

Fungal Presentations



Fungal Presentations from:fungalforum.com

High Dose AmBisome Treatment: what do we know?
By:V-J Anttila, Specialist in Infectious Diseases
Helsinki University Central Hospital, Finland

INVASIVE ASPERGILLOSIS
Management with liposomal amphotericin B
By:Michael Ellis

Is invasive aspergillosis hospital or community acquired: reassessing the evidence?
By:Malcolm Richardson PhD, FIBiol, FRCPath
Department of Bacteriology & Immunology
University of Helsinki, Finland

Invasive fungal infections in immunocompetent patients Does it exists ?

Antifungal combination therapy: where are we?
By:Malcolm Richardson. University of Helsinki.

Emerging fungal pathogens: clinical usefulness of new diagnostic tools

Update on glucan detection
By:Malcolm Richardson PhD, FIBiol, FRCPath
Department of Bacteriology & Immunology
University of Helsinki

Is azole prophylaxis a double-edged sword?
By:Malcolm Richardson PhD, FRCPath
Senior Lecturer in Medical Mycology
University of Helsinki, Finland

Clinical Findings in Rare and Emerging Fungal İnfections
By:Dr. Murat Akova
Hacettepe University School of Medicine
Section of Infectious Diseases
Ankara, Turkey


Liposomal amphotericin B: 20 years of clinical experience
By:Luis Ostrosky-Zeichner, MD, FACP
Assistant Professor of Medicine and Epidemiology
University of Texas Health Science Center at Houston

Antifungal and Surgical Management of a Case of Maxillary Sinus Aspergilloma
By:Riina Rautemaa
DDS, PhD, Consultant of Oral Microbiology
Helsinki University Central Hospital Maxillofacial Clinic and Laboratory Diagnostics;
and Haartman Institute, University of Helsinki, Finland

Read more...

28 July 2009

Nutrition Presentation lectures



Nutrition Presentation lectures
by Dr. Scott Schaeffer
Harford Community College


Lecture notes - Unit 1

Chapter 1
Chapter 2
Chapter 3
Chapter 4

Lecture notes - Unit 2
Chapter 5
Chapter 6
Chapter 7
Chapter 8

Read more...

Male Reproductive System



Male Reproductive System
By:Linda Harmon

Male Reproductive System
* Several organs serve as parts of both the urinary tract and the reproductive systems.
* The structures are the tests, the vas deference and the seminal vesicles, the penis, certain accessory glands, such as the prostate and Cowper’s gland..
* Disorders in these organs may interfere with the function of either or both systems.
* Diseases are usually treated by a urologist.

Health History and Assessment
* Changes in urinary function and symptoms of obstruction caused by an enlarged prostate
* Changes in physical activity
* Sexual function and any manifestations of sexual dysfunction
* Factors that affect sexual functioning (stress, physical disease, use of medications, drugs, or alcohol)

Physical Examination
* Digital-Rectal Exam
o Recommended for every man over the age of 40
o Assess the size, shape, and consistency of the prostate
o Screening for cancer of the prostate
* Testicular Exam
o The male genitalia are inspected for abnormalities
o Note nodules, masses, or inflammation
o Instruct the patient about the technique for TSE

Diagnostic Studies
* Prostate-Specific Antigen
o The prostate gland produces a substance known as Prostate-Specific Antigen (PSA). This is measured in the blood and increases in prostate cancer. It needs to be drawn prior to a rectal exam or urinary catheterization.
* Ultrasound
o Transrectal ultrasound studies are used in detecting nonpalpable prostate cancers and in staging localized prostate cancers,. Needle biopsies of the prostate are commonly guided by ultrasound. Ultrasounds are more sensitive than a digital rectal exam.
* Prostate Fluid or Tissue Analysis
o A biopsy may be necessary to obtain tissue for histologic examination. This can be done with a prostatectomy or via a perineal or transrectal needle biopsy.
* Test of Male Sexual Functioning
o Usually conducted by a special team of health care providers.

Medications Associated with Erectile Dysfunction
* Antiadrenergics and antihypertensives
* Anticholinergics and phenothiazines
* Antiseizure agents
* Antifungals
* Antihormone
* Antipsychotics
* Antispasmodics
* Anxiollytics
* Betablockers
* Calcium channel blockers
* Carbonic anhydrase inhibitors
* H2 antagonists
* Nonsteroidal anti-inflammatory drugs
* Thiazides diuretics
* Tricyclic antidepressant

Conditions of the Prostate

Prostatitis
* Inflammation of the prostate gland caused by infectious agents or other conditions
* Clinical manifestations: perineal discomfort, burning, urgency, frequency and pain with or after ejaculation, fever, chills, rectal or low back pain, urinary tract infections.
* Complications: swelling, urinary retention, epididymitis, bacteremia, pyelonephritis.
* Management: avoid complications, broad spectrum antibiotic agent, bed rest, analgesic agents, antispasmodics, bladder sedatives, sitz baths. Chronic is difficult to treat.
* Nursing Management: antibiotics, comfort measures, analgesics, sitz baths, teaching.
* Self care: administration of antibiotics, sitz baths, fluids encouraged but not forced, foods and liquids with diuretic action or that increase prostatic secretions should be avoided.

Benign Prostatic Hyperplasia
* Enlargement of the prostate, extending upward into the bladder and obstructing the outflow of urine by encroaching on the vesical orifice.
* BPH is one of the most common pathologic conditions in men over 50
* Cause is uncertain
* Hypertrophied lobes cause incomplete emptying and urinary retention.
* Manifestations: frequency, nocturia, urgency, hesitancy, abdominal straining, decrease in volume and force of stream, interruption of stream, dribbling, urinary retention, recurrent UTI, fatigue, anorexia, nausea, vomiting, epigastric discomfort.
* Medical Management: Plan is dependent on cause, severity and condition. Immediate, hormonal, pharmacological, surgical

Cancer of the Prostate
* The most common cancer in men.
* Prostate cancer rates twice as high in African American men. They are more likely to die than men in any other racial or ethnic group.
* Risk factors: increasing age, African American, familial predisposition, diet high in red meat and fat
* Manifestations: urinary obstruction, difficulty and frequency, retention,decrease in size and force of stream, painful ejaculation, hematuria, late signs include backache, hip pain, perineal and rectal discomfort, anemia, weight loss, weakness
* Diagnosis: Early detection increases likelihood of cure. Over 40 requires a digital rectal exam (DRE) – early cancer may be detected as a nodule within the substance of the gland or as an extensive hardening in the posterior lobe.
* Men with prostate cancer experience sexual dysfunction before the diagnosis is made.
* Medical Management: based on the stage, age, symptoms. Surgical management, radiation therapy, hormonal therapy, others.
* Surgical Procedures: the procedure chosen depends on the size of the gland, the severity of the obstruction, the patients age, physical status, presence of associated diseases, and patient preference.
* Complications: hemorrhage, clot formation, catheter obstruction and sexual dysfunction.

Prostatectomy

Read more...

Management of Patients With Gastrointestinal Disorders



Management of Patients With Gastrointestinal Disorders
By:Bonnie Curry

Content Overview
* Overview of GI System
* Assessment
* Diagnostic Evaluation/Nursing Responsibilities
* Pathophysiology of GI Disorders
* Gerontologic Considerations
* Peptic ulcer disease
* GI Bleeding

Overview of GI Tract
* Anatomy
* Physiology
* Parasympathetic Nerve
* Sympathetic Nerve
* Voluntary control
* Functions

Assessment
* Health history
* Clinical manifestations
* Pain
* Indigestion
* Intestinal Gas
* Nausea/Vomiting
* Changes in bowel status

Gerontological Considerations
* Age-related changes in the mouth
* Changes in the esophagus
* Decrease gastric motility
* Decrease absorption of nutrients

Diagnostic Exams/Nursing Considerations
* Nursing Responsibilities
* Provide
* Instruct
* Alleviate
* Help
* Encourage
* Assess

Diagnostic Exams/Nursing Considerations
Endoscopic Studies
* EGD (Esophago-duodenoscopy)
* Lumen of esophagus, stomach, and duodenum
* COLONOSCOPY
* Entire large bowel
* SIGMOIDOSCOPY
* visualizes lower portion of colon-rectum and sigmoid colon

Diagnostic Exams/Nursing Considerations
Endoscopic Studies
* EGD (Esophago-duodenoscopy)
* Lumen of esophagus, stomach, and duodenum

Diagnostic Exams/Nursing Considerations
Endoscopic Studies
* COLONOSCOPY
* Entire large bowel

Diagnostic Exams/Nursing Considerations
Endoscopic Studies
* SIGMOIDOSCOPY
* visualizes lower portion of colon-rectum and sigmoid colon

Diagnostic Exams/Nursing Considerations
Endoscopic Studies
* EGD
* Indications
* Nursing interventions
* Sigmoidoscopy
* Indications
* Nursing interventions
* Colonoscopy
* Indications
* Nursing interventions
* Colon prep

Diagnostic Exams/Nursing Considerations
Radiological Studies
* Upper Gastrointestinal Tract Study (UGI)
* Aids in diagnosis of ulcers, varices, tumors, regional enteritis, and malabsorption syndromes
* Nursing Interventions
* Post Procedure
* Small Bowel Follow Through
* Aids in diagnosis of obstructions, ileitis, and diverticula
* Nursing Interventions
* Post Procedure

Diagnostic Exams/Nursing Considerations
Radiological Studies
* Lower GI Tract Study: Barium Enema (BE)
* Aids in diagnosis of polyps, tumors, other lesions, abnormal anatomy
* Contraindication
* Nursing Interventions
* Post procedure
* Gastric Analysis
* Aids in detection of pyloric or duodenal obstructions, diagnosis of Zollinger-Ellison Syndrome (ZES).
* Nursing Interventions
Diagnostic Exams/Nursing Considerations
Radiological Studies
* Gastric Stimulation Test
* Procedure
* Nursing considerations
* Information obtained
* pH Monitoring
* Procedure
* Nursing considerations
* Information obtained
* Gastric Analysis
* Fluid
* pH
* Basal acid output
* Maximum acid output

Diagnostic Exams/Nursing Considerations
Other Studies
* Ultrasound
* Nursing Interventions
* Computed Tomography (CT Scan)
* Nursing Interventions
* Magnetic Resonance Imaging (MRI)
* Nursing Interventions
* Stool Studies

Peptic Ulcer Disease
* Crater like disruption to GI tract mucosa
* Esophageal
* Gastric
* Small intestine
* Duodenal most common (closest to the stomach)
* Zollinger-Ellison syndrome (ZES)
* Several ulcers
* Extreme gastric hyperacidity
* Tumors of the pancreas
* Resistant to standard medical therapy
* Stress ulcers

Peptic Ulcer Disease
* Clinical Manifestations
* Pain
* burning, gnawing, dull
* midepigastrium or back
* relieved by eating or antacids
* Pyrosis
* Vomiting
* Change in bowel status
* Bleeding
* Gastric Ulcer
* Age 50 & over
* Male:Fem 1:1
* 15% incidence
* Norm. to hyper acid
* Weight loss
* Pain I/2-1hr. After meal
* Pain not relieved by eating
* Vomiting common
* Hemorrhage more likely
* Hematemesis more common
* Duodenal Ulcer
* Age 30-60
* Male:Fem- 2 to 3:1
* 80% incidence
* Hyper acid secretion
* May have wt. Gain
* Pain 2-3 hrs.after meal
* Pain relieved by eating
* Vomiting uncommon
* Hemorrhage less likely
* Melena more common
* Early 1900’s: key variables stress and diet
* Treatment: BR, bland food, hospitalization
* Decades later: primary cause excess gastric acid
* Treatment: antacids, drugs that protect mucosa (Pepto Bismol)
* 1970’s: Histamine receptor acts as key regulator of stomach acid secretion.
* Treatment: H2 blockers -- gastric acid neutralized and secretion reduced (tagamet, zantac, pepcid, axid)
* Newer drug class-- proton pump inhibitors -- longer & more complete blocking of acid formation (prilosec, prevacid, protonix)
* 1980’s: Discovery of Bacterium Helicobacter pylori (H. pylori)
Combination of antibiotics and acid suppressors Antacids,tranquilizers, lifestyle and dietary changes, surgery

Treatment ...
Peptic Ulcer Disease:

Read more...

26 July 2009

Medical Calculators



Hematology, CRCL, Dermatology, Diabetes, Disease Prediction, ICU, Infectious disease, Kinetic dosing, Nutrition, Oncology, Drug Comparisons, Drip rate, Dieting / Exercise, Fluids and Electrolytes calculators are available here.

Pregnancy Due-Dates and other medical Calculators



MedCalc: Pregnancy Due-Dates Calculator

General, Cardiology, Drugs / Pharm, Fluids / Electrolytes, Pulmonary, Renal calculators are also available here.

http://www.medcalc.com/pregnancy.html

Common laboratory values



Common laboratory values, Therapeutic Drug levels, Interpretation of lab results, Urinalysis etc.

Values given at this site are realistic.

http://www.globalrph.com/labs_home.htm

Pharmacology Presentations Part-4



Pharmacology Presentations from Howard University College of Medicine

Drug Abuse – Hallucinogenic Drugs
By:Robert L. Copeland, Jr., Ph.D.

Drugs of Abuse: Opiates
By:Robert L. Copeland, Jr., Ph.D.

Drugs of Abuse Part V Inhalants
By:Martha I. Dávila-García, Ph.D.

Opioid Agonists And Antagonists
By: Dr. Robert L. Copeland

CNS Depressants Sedative/Hypnotics
By:Dr. Martha I. Dávila-García

Non-Metallic Environmental Toxicants
By: Sidney Green Ph.D

Good Laboratory Practices
By:Sidney Green, Ph.D.

Dyslipidemia
By:GETU ASSEFA M.D.

Pharmacology Presentations Part-3



Pharmacology Presentations from Howard University College of Medicine

Heavy Metals And Heavy Metal Antagonists 1, 2
By:Robert L. Copeland, Jr., Ph.D.

Therapeutic Gases - Oxygen
By:Robert L. Copeland, Ph.D.

Parkinson's Disease
By:Robert L. Copeland, Ph.D.

Biotransformation of Xenobiotics
By:Barbara M. Davit, PhD, DABT

Drug Metabolism

Pharmacology 1, 2
By:Dr. Martha I. Dávila-García

Drug Development and Regulation
By: Joseph Hanig, Ph.D.

Drugs of Abuse
By:Martha I. Dávila-García, Ph.D.

Drugs of Abuse Part-1
Martha I. Dávila-García, Ph.D.

Pharmacology Presentations Part-2



Pharmacology Presentations from Howard University College of Medicine

Introduction to Toxicology 1, 2 , 3
By:SIDNEY GREEN, PH.D.

Alcohols - Monohydroxyl Alcohols
By:Dr. Akinshola

Local Anesthetics
By:Robert L. Copeland, Ph.D

CNS Stimulants 1, 2
1.By:Robert L. Copeland, Ph.D.
2.Martha I. Dávila-García, Ph.D.

Cancer Chemotherapy
By:Jillian H. Davis

Introduction to the Databases of National Library of Medicine
By:Robert L. Copeland,Ph.D.

Drug-Receptor Interactions
By:Dr. Robert L. Copeland

The Parasympathetic Nervous System 1, 2, 3

Cell Wall Inhibitors
By:Robert L. Copeland, Ph.D.

Pharmacology Presentations Part-1



Pharmacology Presentations from Howard University College of Medicine

Anticoagulant, Antithrombotic and Anti-Platelet Drugs
By: Robert Taylor, MD, Ph.D.

Antiviral Agents
By:Jillian H. Davis

Antiepileptic Drugs 1, 2, 3, 4
By:Martha I. Dávila-García, Ph.D.

Routes of Drug Administration 1, 2, 3
By:Robert L. Copeland, Ph.D.

Tetracyclines, 2
By:Martha I. Dávila-García, Ph.D.

Pediatric and Perinatal Pharmacology
By: Martha I. Dávila-García, Ph.D.

Antiepileptic Drugs
By:Martha I. Dávila-García, Ph.D

Penetration of drug into the eye after systemic Administration

Antidepressants
By:Martha I. Dávila-García, Ph.D.

Clinical Toxicology
By:Joseph Hanig, Ph.D.

Acid-Peptic Disease PUD/GERD/NSAIDs
By:Duane T. Smoot, M.D., FACP, FACG

All links posted here are collected from various websites. No video or powerpoint files are uploaded on this blog. If you are the original author and do not wish to display your content on this blog please Email me anandkumarreddy at gmail dot com I will remove it. The contents of this blog are meant for educational purpose and not for commercial use. If you use any content give due credit to the original author.

This site uses cookies from Google to deliver its services, to personalise ads and to analyse traffic. Information about your use of this site is shared with Google. By using this site, you agree to its use of cookies.

  © Blogger templates Newspaper III by Ourblogtemplates.com 2008

Back to TOP